Growth hormone increases interleukin-6 produced by human osteoblast- like cells

Journal of Clinical Endocrinology and Metabolism

Volumn 81, Issue 12, 1996, Pages 4329-4333

  Swolin, D ^a   Ohlsson, C ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER; INTERLEUKIN 6;

ARTICLE; BONE METABOLISM; BONE MINERAL; BONE REMODELING; CELL PROLIFERATION; GROWTH HORMONE RELEASE; HORMONAL REGULATION; HUMAN; HUMAN CELL; OSTEOBLAST; OSTEOLYSIS; PRIORITY JOURNAL; STEM CELL; T LYMPHOCYTE ACTIVATION;

CELLS, CULTURED; GROWTH HORMONE; HUMANS; INTERLEUKIN-6; OSTEOBLASTS; RNA, MESSENGER;

EID: 0029823150     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.81.12.4329     Document Type: Article

References (50)

1. Takahashi N, Akatsu T, Udagawa N, Sasaki T, Yamaguchi A, Moseley JM. 1988 Osteoblastic cells are involved in osteoclast formation. Endocrinology. 123:2600-2602.
2. Rosén T, Hansson T, Granhed H, Szücs J, Bengtsson BA. 1993 Reduced bone mineral content in adult patients with growth hormone deficiency. Acta Endocrinol (Copenh). 129:201-206.
3. Saggese G, Baroncelli GI, Bertelloni S, Cinquanta L, Di Nero G. 1993 Effects of long-term treatment with growth hormone on bone and mineral metabolism in children with growth hormone deficiency. J Pediatr. 122:37-45.
4. Rosén T, Johansson G, Hallgren P, Caidahl K, Bosaeus I, Bengtsson BÅ. 1994 Beneficial effects of 12 months replacement therapy with recombinant human growth hormone to growth hormone deficient adults. Endocrinol Metab. 1:55-66.
5. Wüster C, Slenczka E, Ziegler R. 1991 Erhöhte Prävalenz von Osteoporose and Arteriosklerose bei konventionell substituierter Hypophysenvorderlappenin-suffizienz: Bedarf einer zusätzlichen Wachstumshormonsubstitution?. Klin Wochenschr. 69:769-773.
6. Rosén T, Wilhelmsen L, Landin-Wilhelmsen K, Lappas G, Lindstedt G, Bengtsson BÅ. Increased fracture rate in growth hormone (GH) deficient adults. Proc of the 77th Annual Meet of The Endocrine Soc. 1995; 353.
7. Kassem M, Blum W, Ristelli J, Mosekilde L, Eriksen EF. 1993 Growth hormone stimulates proliferation and differentiation of normal human osteoblast-like cells in vitro. Calcif Tissue Int. 52:222-226.
8. Morel G, Chavassieux P, Barenton B, Dubois PM, Meunier PJ, Boivin G. 1993 Evidence for a direct effect of growth hormone on osteoblasts. Cell Tissue Res. 273:279-286.
9. Nilsson A, Swolin D, Enerbäck S, Ohlsson C. 1995 Expression of functional growth hormone receptors in cultured human osteoblast-like cells. J Clin Endocrinol Metab. 80:3483-3488.
10. Halse J, Melsen F, Mosekilde L. 1981 Iliac crest bone mass and remodeling in acromegaly. Acta Endocrinol (Copenh). 97:18-22.
11. Ezzat S, Melmed S, Endres D, Eyre DR, Singer FR. 1993 Biochemical Assessment of bone formation and resorption in acromegaly. J Clin Endocrinol Metab. 76:1452-1457.
12. Riggs BL, Randall RV, Wahner HW, Jowsey J, Kelly PJ, Singh M. 1972 The nature of metabolic bone disorder in acromegaly. J Clin Endocrinol Metab. 34:911-918.
13. Lewinson D, Shenzer P, Hochberg Z. 1993 Growth hormone involvement in the regulation of tartrate-resistant acid phospatase-positive cells that are active in cartilage and bone resorption. Calcif Tissue Int. 52:216-221.
14. Brixen K, Nielsen HK, Mosekilde L, Flyvbjerg A. 1990 A short course of recombinant human growth hormone treatment stimulates osteoblasts and activates bone remodeling in normal human volunteers. J Bone Miner Res. 5:609-618.
15. Brixen K, Kassem M, Nielsen HK, Loft AG, Flyvbjerg A, Mosekilde L. 1995 Short-term treatment with growth hormone stimulates osteoblastic and osteoclastic activty in osteopenic postmenopausal women: A dose response study. J Bone Miner Res. 10:1865-1874.
16. Nishiyama K, Sugimoto T, Kaji H, Kanatani M, Kobayashi T, Chihara K. 1996 Stimulatory effect of growth hormone on bone resorption and osteoclast differentiation. Endocrinology. 137:35-41.
17. Kopf M, Baumann H, Freer G, et al. 1994 Impaired immune and acute-phase responses in interleukin-6 deficient mice. Nature. 368:339-342.
18. Black K, Garrett IR, Mundy GR. 1991 Chinese hamster ovarian cells transfected with the murine interleukin-6 gene cause hypercalcemia as well as cachexia, leukocytosis and thrombocytosis in tumor-bearing nude-mice. Endocrinology. 128:2657-2659.
19. Kurihara N, Bertolini D, Suda T, Akiyama Y, Roodman GD. 1990 IL-6 stimulates osteoclast-like multinucleated cell formation in long-term human marrow cultures by inducing IL-1 release. J Immunol. 144:4226-4230.
20. Kurihara N, Civin C, Roodman GD. 1991 Osteotropic factor responsiveness of highly purified populations of early and late precursors for human multinucleated cells expressing the osteoclast phenotype. J Bone Miner Res. 6:257-261.
21. 3 on the production of prostaglandins by cells derived from human bone. FEBS Lett. 169:49-52.
22. Durnam DM, Palmiter RD. 1983 A practical approach for quantitating specific mRNAs by solution hybridization. Anal Biochem. 131:385-393.
23. Chomczynski P, Sacchi N. 1987 Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 162:156-159.
24. Brakenhoff JP, de Groot ER, Evers RF, Pannekoek H, Aarden LA. 1987 Molecular cloning and expression of hybridoma growth factor in Escherichia coll. J Immunol. 15:4116-4121.
25. Mathews LS, Norstedt G, Palmiter RD. 1986 Regulation of insulin-like growth factor I gene expression by growth hormone. Proc Natl Acad Sci USA. 83:9343-9347.
26. Labarca C, Paigen K. 1980 A simple, rapid, and sensitive DNA assay procedure. Anal Biochem. 102:344-352.
27. Feyen JHM, Elford P, Di Padova FE, Trechsel U. 1989 Interleukin-6 is produced by bone and modulated by parathyroid hormone. J Bone Miner Res. 4:633-638.
28. Helle M, Brakenhoff JPJ, De Groot ER, Aarden LA. 1988 Interleukin-6 is involved in Interleukin-1-induced activities. Eur J Immunol. 18:957-959.
29. Littlewood AJ, Russel J, Harvey GR, Hughes DE, Russel RGG, Gowen M. 1991 The modulation of the expression of IL-6 and its receptor in human osteoblasts in vitro. Endocrinology. 129:1513-1520.
30. Franchimont N, Canalis E. 1995 Platelet-derived growth factor stimulates the synthesis of Interleukin-6 in cells of the osteoblast lineage. Endocrinology. 136:5469-5475.
31. Tarjan G, Stern PH. 1995 Triiodothyronine potentiates the stimulatory effects of interleukin-1 β on bone resorption and medium interleukin-6 content in fetal rat limb bone cultures. J Bone Miner Res. 10:1321-1326.
32. Slootweg MC, Most WW, Beek EV, Schot LPC, Papapoulos SE, Löwik CWGM. 1992 Osteoclast formation together with interleukin-6 production in mouse long bones is increased by insulin-like growth factor-1. J Endocrinol. 132:433-438.
33. 3. J Clin Invest. 91:1731-1742.
34. Jilka RL, Hangoc G, Girasole G, et al. 1992 Increased osteoclast development after estrogen loss: mediation by Interleukin-6. Science. 257:88-91.
35. Poli V, Balena R, Fattori E, Markatos A, et al. 1994 Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion. EMBO J. 13:1189-1196.
36. Girasole G, Jilka RL, Passen G, et al. 1992 17β-Estradiol inhibits interleukin-6 production by bone-marrow derived stromal cells and osteoblasts in vitro: a potential mechanism for the antiosteoporotic effect of estrogens. J Clin Invest. 89:883-891.
37. Stein B, Yang MX. 1995 Repression of the Interleukin-6 promotor by estrogen receptor is mediated by NF-κB and C/EBPβ. Mol Cell Biol. 15:4971-4979
38. Pottratz ST, Bellido T, Mocharia H, Crabb D, Manolagas SC. 1994 17-β Estradiol inhibits expression of human interleukin-6 promoter-reporter constructs by a receptor-dependent mechanism. J Clin Invest. 93:944-950.
39. Chaudhary LR, Spelsberg TC, Riggs BL. 1992 Production of various cytokines by normal human osteoblast-like cells in response to interleukin-1β and tumor necrosis factor-α: lack of regulation by 17β-estradiol. Endocrinology. 130:2528-2534.
40. Rifas L, Kenney JS, Marcelli M, et al. 1995 Production of Interleukin-6 in human osteoblasts and human bone marrow stromal cells: evidence that induction by Interleukin-1 and tumor necrosis factor-α is not regulated by ovarian steroids. Endocrinology. 136:4056-4067.
41. Kimble RB, Bain SD, Kung V, Pacifici R. 1995 Inhibition of IL-6 activity in genetically normal mice does not prevent ovariectomy-induced bone loss. J Bone Miner Res. 10(Suppl):S160.
42. Ohlsson C, Lövstedt K, Holmes PV, Nilsson A, Carlsson L, Törnell J. 1993 Embryonic stem cells express growth hormone receptors: regulation by retinoic acid. Endocrinology. 133:2897-2903.
43. Ohlsson C, Nilsson A, Isaksson O, Lindahl A. 1992 Growth hormone induces multiplication of the slowly cycling germinal cells of the rat tibial growth plate. Proc Natl Acad Sci USA. 89:9826-9830.
44. Green H, Morikawa M, Nixon T. 1985 A dual effector theory of growth hormone action. Differentiation. 29:195-198.
45. Nixon BT, Green H. 1984 Growth hormone promotes the differentiation of myoblasts and preadipocytes generated by azacytidine treatment of 10T1/2 cells. Proc Natl Acad Sci USA. 81:3429-3432.
46. Kassem M, Mosekilde L, Eriksen EF. 1994 Growth hormone stimulates proliferation of normal human bone marrow stromal osteoblast precursor cells in vitro. Growth Regul. 4:131-135.
47. Van Deweghe M, Taelman P, Kaufman JM. 1993 Short and long term treatment on bone turnover and bone mineral content in adult growth hormone-deficient males. Clin Endocrinol (Oxf). 39:409-415.
48. Degerblad M, Elgindy N, Hall K, Sjöberg HE, Thoren M. 1992 Potent effect of recombinant growth hormone on bone mineral density and body composition in adults with panhypopituitarism. Acta Endocrinol (Copenh). 126:387-393.
49. Johansson G, Rosen T, Boseaus I, Sjöström L, Bengtsson BA. 1996 Long-term growth hormone treatment increases bone mineral content and density in patients with adult-onset growth hormone deficiency. J Clin Endocrinol Metab. 81:2865-2873.
50. Andreassen TT, Jørgensen PH, Flyvbjerg A, Ørskov H, Oxlund H. 1995 Growth hormone stimulates bone formation and strength of cortical bone in aged rats. J Bone Miner Res. 10:1057-1067.